# HepaGam B

NDC: 49591-052
Generic name: HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN
Labeler / Manufacturer: Kamada Ltd.
Product type: PLASMA DERIVATIVE
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20251001

FDA application: BLA125035

## Active ingredients

- HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN: 312 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"49591-052"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=49591-052